{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06057454",
            "orgStudyIdInfo": {
                "id": "RISE R-5280"
            },
            "organization": {
                "fullName": "Rise Therapeutics LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "R-5280 in Newly Diagnosed Patients With Type 1 Diabetes",
            "officialTitle": "Evaluating the Safety and Tolerability of R-5280 in Mitigating Type 1 Diabetes in Newly Diagnosed Patients",
            "acronym": "R-5280",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "r-in-newly-diagnosed-patients-with-type-diabetes"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2023-12-05",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-09-15",
            "studyFirstSubmitQcDate": "2023-09-21",
            "studyFirstPostDateStruct": {
                "date": "2023-09-28",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Rise Therapeutics LLC",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Evaluating the adverse events and tolerance of R-5280 in Mitigating Type 1 Diabetes in Newly Diagnosed Patients",
            "detailedDescription": "Double blinded, placebo controlled, Phase 1B study assessing the safety and efficacy of 12 weeks daily administrations of R-5280 in newly diagnosed Type 1 Diabetes adolescents"
        },
        "conditionsModule": {
            "conditions": [
                "Type 1 Diabetes",
                "Type 1 Diabetes (Juvenile Onset)",
                "Diabetes Mellitus, Type 1"
            ],
            "keywords": [
                "Type 1 Diabetes"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Double Blinided, placebo controlled, Phase 1B study.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "maskingDescription": "Double blind placebo controlled trial",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 39,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Active Comparator",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "R-5280, Taken Twice a day, orally with food for 12 weeks (84 days)",
                    "interventionNames": [
                        "Drug: R-5280"
                    ]
                },
                {
                    "label": "Placebo Comparator",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Food starch, taken twice a day, orally with food for 12 weeks (84 days)",
                    "interventionNames": [
                        "Other: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "R-5280",
                    "description": "Modified Superior Starch",
                    "armGroupLabels": [
                        "Active Comparator"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Placebo",
                    "description": "Food Grade Starch",
                    "armGroupLabels": [
                        "Placebo Comparator"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Measurement of adverse events from the date of the first dose through 12 weeks of R-5280 tolerance",
                    "description": "The number of participants with treatment-related adverse events as evaluated by CTCAE v5.0, will be reviewed to see the results from baseline in toxicology scores at 12 Weeks compared to placebo.",
                    "timeFrame": "12 Weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Measurement of clinical activity and to determine the gut microbiome profile in youth with recently diagnosed Type 1 Diabetes",
                    "description": "To measure the levels of glucose (in milligrams) in the blood at the beginning and again at 12 weeks, and the measurement of C-Peptide (in nanograms) in the blood at the beginning and again at 12 weeks versus placebo, changes in the type of gut bacteria at the beginning and again at 12 weeks versus placebo.",
                    "timeFrame": "12 Weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Newly Diagnosed children (age 11-17 years old)\n* BMI \\<85%\n* Diagnosed by ADA criteria with T1D within 2 years\n* Accepted to adhere to a healthy diabetic diet as recommended by the ADA\n\nExclusion Criteria:\n\n* Monogenic forms of diabetes or type 2 diabetes\n* History of ongoing infection or antibiotic treatment within the past four (4) weeks\n* History of immunocompromised, recurrent infections, steroid intake (inhaled or oral forms) or other immunosuppressant use in the past six (6) months\n* History of chronic gastrointestinal disease, possible or confirmed celiac disease\n* Pregnancy or possible pregnancy\n* Allergy to corn (prebiotic), milk allergy, soy (present in the MMTT meal) or their products\n* Participation in other intervention research trials within the past three (3) months\n* Anticipated major change in diabetes management during the study (e.g., change from injections to insulin pump therapy or new continuous monitor usage, all known to significantly alter glycemia)\n* Children consuming a high-fiber or vegetarian diet (consuming three (3) or more servings of high fiber foods on four (4) or more days per week) or any fiber supplements will be excluded (to be assessed at screening)\n* Any COVID vaccines within 30 days prior to Day 1",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "11 Years",
            "maximumAge": "17 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Janet Stephens, PhD",
                    "role": "CONTACT",
                    "phone": "6504178556",
                    "email": "jstephens@risetherapeutics.com"
                },
                {
                    "name": "Christian Freguia, PhD",
                    "role": "CONTACT",
                    "phone": "2159231818",
                    "email": "cfreguia@risetherapeutics.com"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Janet Brinkman",
                            "role": "CONTACT",
                            "phone": "507-538-0298",
                            "email": "brinkman.janet@mayo.edu"
                        },
                        {
                            "name": "Ana Creo, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                },
                {
                    "facility": "Spectrum Clinical Research",
                    "status": "RECRUITING",
                    "city": "Kansas City",
                    "state": "Missouri",
                    "zip": "64118",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jovanna Schlossenberg",
                            "role": "CONTACT",
                            "phone": "816-562-6466",
                            "email": "jovanna@spectrumclinicalresearch.com"
                        },
                        {
                            "name": "Evan J Russell, DO",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.09973,
                        "lon": -94.57857
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000003922",
                    "term": "Diabetes Mellitus, Type 1"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7117",
                    "name": "Diabetes Mellitus, Type 1",
                    "asFound": "Type 1 Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "asFound": "Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}